LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Art Pappas will be on a panel titled "Update on Capital Availability for Indiana Companies" at Burrill's Indiana Life Sciences Forum in Indianapolis, IN
News | 10. 21. 2008
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.